Landscapes / Companies
Keymed Biosciences Co.Ltd not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
13
in active trials · 14 in all
Trials
29 active
68 since 2021
Drugs13
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Artificial immunoglobulin |
Approved in China | Dec 2026Phase 3 trial completes | |||
| How it works | An antibody | ||||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Atopic Dermatitis, Seasonal Allergic Rhinitis (SAR) and 3 more | ||||
| Open drug page | |||||
— |
Phase 3 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Multiple Myeloma (MM), Multiple Myeloma and 6 more | ||||
| Open drug page | |||||
— |
Phase 3 | Mar 2027Phase 2 trial completes | |||
| Next date | Mar 2027 · Phase 2 trial completes | ||||
| Also tested for | Primary Immune Thrombocytopenia, Systemic Lupus Erythematosus and 4 more | ||||
| Open drug page | |||||
— |
CSPC Baike (Shandong) Biopharmaceutical |
Phase 3 | 1 Jul 2027Phase 2 trial completes | ||
| Next date | 1 Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Moderate to Severe Asthma, Chronic Obstructive Pulmonary Disease and 1 more | ||||
| Open drug page | |||||
— |
Phase 3 | 21 Jul 2027Phase 2 trial completes | |||
| Next date | 21 Jul 2027 · Phase 2 trial completes | ||||
| Also tested for | Atopic Dermatitis, Chronic Obstructive Pulmonary Disease and 6 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Apr 2027Phase 1/2 trial completes | |||
| Next date | Apr 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Jun 2027Phase 2 trial completes | |||
| Next date | 30 Jun 2027 · Phase 2 trial completes | ||||
| Also tested for | IgA Nephropathy | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2028Phase 1/2 trial completes | |||
| Next date | 31 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2029Phase 1/2 trial completes | |||
| Next date | 31 Dec 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Dec 2026Phase 1 trial completes | |||
| Next date | 30 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Alzheimer Disease | ||||
| Open drug page | |||||
— |
Phase 1 | Jul 2027Phase 1 trial completes | |||
| Next date | Jul 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Phase 1 | Sep 2027Phase 1 trial completes | |||
| Next date | Sep 2027 · Phase 1 trial completes | ||||
| Also tested for | Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Open drug page | |||||
No drugs match “”.
About
- No active trial
- CMG901
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021